Essent debuts new stem cells for research

By The Science Advisory Board staff writers

June 9, 2021 -- Nonprofit biotechnology firm Essent Biologics has launched human mesenchymal stem cells (hMSCs) for applications in regenerative medicine and biopharmaceutical and cell therapy research.

The stem cells are recovered, expanded, and cryopreserved without the use of antibiotics or animal products. To ensure potency, each vial contains more than 1 million cells at thaw and a passage level of P0 or P1.

Full donor information and a source biopsy are also available with each stem cell order.

Essent Biologics has launched human mesenchymal stem cells for regenerative medicine and biopharmaceutical and cell therapy research.
Essent Biologics has launched human mesenchymal stem cells for regenerative medicine, biopharmaceutical, and cell therapy research. Image courtesy of Essent Biologics.

Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.